Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis)
Featured Articles
(Medscape Medical News) Aug 22, 2017 - Azacitidine (Vidaza, Celgene) is standard treatment for patients with myelodysplastic syndrome (MDS) and will remain the treatment of choice — at least for now.
Read Article
(Yahoo! Finance) Aug 21, 2017 - Syros Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to SY-1425 for the treatment of acute myeloid leukemia (AML).
Read Article
Latest Articles
August 21, 2017
August 21, 2017
August 21, 2017
August 21, 2017
August 18, 2017
August 18, 2017
August 18, 2017
August 18, 2017
View More
News Commentary
Editor Image
21 Apr, 2017 | by Dean Gesme, MD
This will only determine how much delay is allowed by the courts and how...
View Comment
Editor Image
26 Apr, 2017 | by Howard S. Hochster, MD
Fascinating legal wrangling as the Supremes parse the wording of the BPCIA...
View Comment
View More
OBR Green
There are no Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis) OBR Green articles.
OBR Blog
This year's ASH Annual Meeting will be chock-full of interesting, informative, and clinically useful presentations,... Read more
November 22, 2016